Status:
COMPLETED
Vasopressor Prophylaxis After Spinal Anesthesia
Lead Sponsor:
Cairo University
Conditions:
Cesarean Section Complications
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
Norepinephrine has been recently introduced as a prophylactic vasopressor during Cesarean delivery with promising results ; However, the optimum dose for efficient prophylaxis with the least side effe...
Detailed Description
Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Using vasopressors have been considered a gold standard for prevention of post-spinal hypotension (PSH...
Eligibility Criteria
Inclusion
- full term singleton pregnant women
- Scheduled for elective Cesarean Delivery
- Aged between 18 and 40 years
Exclusion
- Cardiac morbidities
- Hypertensive disorders of pregnancy,
- Peripartum bleeding
- Baseline systolic blood pressure (SBP) \< 100 mmHg
- Body mass index \> 35
Key Trial Info
Start Date :
August 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2018
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT03234816
Start Date
August 2 2017
End Date
December 10 2018
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt